Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gains
Quite a high number of new vaccines have been introduced into the global healthcare programme during the past 15 years. Among them vaccines against Streptococcus pneumonia, rotavirus, human papillomavirus, Neisseria meningitides, varicella zoster virus (responsible for herpes zoster), dengue, and new ones against influenza viruses [1], are now in the market, but others against malaria and Ebola are coming soon [2].
Source: Health Policy - Category: Health Management Authors: Baudouin Standaert, Nadia Schecroun, Olivier Ethgen, Oleksandr Topachevskyi, Yoriko Morioka, Ilse Van Vlaenderen Source Type: research
More News: Cervical Cancer Vaccine | Dengue Fever | Ebola | Ebola Vaccine | Genital Warts | Health Management | Herpes | Human Papillomavirus (HPV) | Influenza | Influenza Vaccine | Japan Health | Malaria | Malaria Vaccine | Men | Pneomococcal Vaccine | Pneumonia | Rotavirus | Rotavirus Vaccine | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine